MicroRNAs as a therapeutic target for cardiovascular diseases
about
Inhibition of microRNA-29b reduces murine abdominal aortic aneurysm developmentMicroRNA-21 blocks abdominal aortic aneurysm development and nicotine-augmented expansionMicromanaging abdominal aortic aneurysmsCardiac matrix: a clue for future therapyMicroRNAs: a new ray of hope for diabetes mellitusDifferential expression of dicer, miRNAs, and inflammatory markers in diabetic Ins2+/- Akita heartsMechanical stretch via transforming growth factor-β1 activates microRNA208a to regulate endoglin expression in cultured rat cardiac myoblastsmiR-24 limits aortic vascular inflammation and murine abdominal aneurysm development.Long-term miR-29b suppression reduces aneurysm formation in a Marfan mouse model.Redox regulation of microRNAs in endometriosis-associated pain.Anticancer Role of PPARgamma Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes.Differential expression of microRNAs following cardiopulmonary bypass in children with congenital heart diseasesH2S and homocysteine control a novel feedback regulation of cystathionine beta synthase and cystathionine gamma lyase in cardiomyocytes.MicroRNAs are involved in homocysteine-induced cardiac remodeling.MicroRNA-133a regulates DNA methylation in diabetic cardiomyocytes.MicroRNA expression analysis: clinical advantage of propranolol reveals key microRNAs in myocardial infarction.Clarifying mammalian RISC assembly in vitroStem cells as a therapeutic target for diabetes.MMP-9 gene ablation and TIMP-4 mitigate PAR-1-mediated cardiomyocyte dysfunction: a plausible role of dicer and miRNA.MicroRNAs and the regulation of fibrosis.Comprehensive exploration of the effects of miRNA SNPs on monocyte gene expressionRole for miR-204 in human pulmonary arterial hypertensionMicroRNA-27b regulates the expression of matrix metalloproteinase 13 in human osteoarthritis chondrocytes.MicroRNA-23a participates in estrogen deficiency induced gap junction remodeling of rats by targeting GJA1.Novel microRNA prosurvival cocktail for improving engraftment and function of cardiac progenitor cell transplantation.MicroRNA-134 as a potential plasma biomarker for the diagnosis of acute pulmonary embolism.MicroRNA-1 transfected embryonic stem cells enhance cardiac myocyte differentiation and inhibit apoptosis by modulating the PTEN/Akt pathway in the infarcted heart.Induction of autophagy markers is associated with attenuation of miR-133a in diabetic heart failure patients undergoing mechanical unloading.The effects of phosphodiesterase-5 inhibitor sildenafil against post-resuscitation myocardial and intestinal microcirculatory dysfunction by attenuating apoptosis and regulating microRNAs expression: essential role of nitric oxide syntheses signalinInhibition of microRNA-497 ameliorates anoxia/reoxygenation injury in cardiomyocytes by suppressing cell apoptosis and enhancing autophagySilencing of miR-195 reduces diabetic cardiomyopathy in C57BL/6 miceMicroRNA-199a* regulates the expression of cyclooxygenase-2 in human chondrocytes.Local MicroRNA Modulation Using a Novel Anti-miR-21-Eluting Stent Effectively Prevents Experimental In-Stent RestenosismiR-31 is a negative regulator of fibrogenesis and pulmonary fibrosis.Predictors and prevention of diabetic cardiomyopathy.miR-145 regulates myofibroblast differentiation and lung fibrosis.Emerging role of hydrogen sulfide-microRNA crosstalk in cardiovascular diseases.Oncostatin M-induced cardiomyocyte dedifferentiation regulates the progression of diabetic cardiomyopathy through B-Raf/Mek/Erk signaling pathway.MicroRNA-29b regulation of abdominal aortic aneurysm development.The therapeutic effect of rosuvastatin on cardiac remodelling from hypertrophy to fibrosis during the end-stage hypertension in rats.
P2860
Q24303139-AE06FBEB-C7F1-41E5-9039-8A9ED1D5D822Q24305799-0B8F9D1A-5EBC-4D23-8292-C3ECA485C629Q26823361-1113C781-5FA6-4905-9434-4686E0F5B57FQ27026864-FD9EA693-F1FE-48FC-B6FC-324A8A50A170Q27028201-598802D3-D47C-4714-9E43-5ED9F5E2A45DQ28293366-1F8086DC-4446-40C1-A535-A04ABDBB3B06Q28568593-D3C89388-9DE3-4804-99F0-9E2F662CCB37Q30596758-84BB5070-9E79-4BF9-884D-1AC7008D8C18Q33612367-BC21EDEB-6AB6-4065-8CCB-99B8A3BACF0BQ33676118-6A73C993-13A1-45CB-BF02-C1F787786EB1Q33692555-20A6347C-60FF-46AA-AFFA-78B362558664Q33742505-F9435DB7-41D4-4581-A003-037903EC2BB0Q33808178-769D13E4-E84A-47B0-9864-DC36625A488AQ33824386-C46D7987-AE93-4772-83FE-2B523F77B1BBQ33829505-1423533D-794F-4E44-A729-FE4133301511Q33840744-67D5DB59-102C-4330-9537-336F45329EA2Q33884920-33FA5D51-570A-4BD2-979A-00F4ACBB9049Q33982394-F5324FE9-511A-4B62-85CD-F88AA2E73F8AQ34066783-591E81B0-269E-4993-B7CE-084681AEB773Q34238322-94C9C52C-3C1E-46D1-8026-C53CDFCBA513Q34430255-C4255053-792E-4C92-8860-CD0B931AE7BAQ34681312-FCCE6BE3-B007-42E2-AA75-51648241B4A5Q35114604-037642A7-8201-4E31-BEC4-A8509C903E82Q35197492-4FA1FF86-659B-41B0-BA60-9735ED0F3B9BQ35234806-62F08018-1588-4A15-B66D-1BEA12ADF30EQ35298762-F741BEE3-C206-4E9B-A55A-50C35C1A7965Q35543468-6B7EACC4-91D5-4AA6-B50C-80FB864657B6Q35682591-37CD240F-190B-49AF-AFD5-6E4710DBE34EQ35743087-9FAE020C-43A7-4317-8BC7-FDD91E67EADBQ35753293-A532D0FC-7C8F-4B10-B245-FE137B33DEE9Q35843423-64264AD6-90C7-4905-AC7D-69AC3F7DE838Q35875196-C84BA653-BE5C-49D7-AC46-14FA78D874DDQ36004612-448A5A3D-7E26-4BA4-A0DC-35BECF53A6AEQ36183735-08A5539D-028C-4D34-8ED8-7F256033210BQ36776922-9A2FCE03-CD8D-4A08-9E7A-DF9A87210B0AQ36860296-16C39E7A-51F2-4528-936B-C8E3DBC5CBB4Q36902427-A91B7998-DEE4-429B-9C36-A2DEC2166E47Q36947121-4A4173AD-CC67-4248-865D-377C4C84876DQ37275059-971BBBD0-EA2D-4637-A53E-677FCD1492DFQ37294951-FE3FBE40-905E-4ED3-984A-05407A00B2FA
P2860
MicroRNAs as a therapeutic target for cardiovascular diseases
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MicroRNAs as a therapeutic target for cardiovascular diseases
@en
MicroRNAs as a therapeutic target for cardiovascular diseases.
@nl
type
label
MicroRNAs as a therapeutic target for cardiovascular diseases
@en
MicroRNAs as a therapeutic target for cardiovascular diseases.
@nl
prefLabel
MicroRNAs as a therapeutic target for cardiovascular diseases
@en
MicroRNAs as a therapeutic target for cardiovascular diseases.
@nl
P2093
P2860
P1476
MicroRNAs as a therapeutic target for cardiovascular diseases
@en
P2093
Munish Kumar
Neetu Tyagi
Paras Kumar Mishra
Suresh C Tyagi
P2860
P304
P356
10.1111/J.1582-4934.2009.00744.X
P577
2009-03-13T00:00:00Z
2009-04-01T00:00:00Z